1Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia JAMA,2002,287(24):3183-3186
2Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies.BMJ,2005,330(7491):565
3Red-Horse K, Zhou Y, Genbacev O, et al. Trophoblast differentiation during embryo implantation and formation of the maternal-fetal intedace. J Clin Invest, 2004, 114(6): 744-754
4Jauniaux E, Gulbis B, Burton GJ. The human first trimester gestational sac limits rather than facilitates oxygen transfer to the foetus-a review. Placenta, 2003, 24[Suppl A]:S86-93
5Hiby SE, Walker JJ, O'shaughnessy KM, et al. Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J Exp Med, 2004,200(8):957-965
6Parharn P. MHC class I molecules and KIRs in human history, health and survival.Nat Rev Immunol, 2005,5(3):201-214
7Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol,2002,2(9):656-663
8Trundley A, Moffett A. Human uterine leukocytes and pregnancy.Tissue Antigens,2004,63(1): 1-12
9Cooper MA, Fehninger TA, Turner SC, et al. Human natural killer cells: a unique innate immunoregulatory role for the CD56 bright subset. Blood,2001,97(10):3146-3151
10Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol,2002,20:217-251
